Warning Letter — Pamex Foods Incorporated
The FDA issued a Warning Letter to Pamex Foods Incorporated following an inspection by the Office of Inspections and Investigations.
This update affects Pamex Foods Incorporated and its internal departments responsible for food safety, quality assurance, and manufacturing compliance.
The issuance of a Warning Letter signifies that the FDA has identified significant violations of regulatory requirements. For food manufacturers, this typically involves deviations from current Good Manufacturing Practice (cGMP) or food safety regulations, which may lead to further administrative or judicial action if not remediated promptly. The specific nature of the violations is not detailed in the provided excerpt, but such letters generally indicate systemic failures in quality oversight.
Quality and Regulatory teams should conduct a comprehensive audit of their facility against current Good Manufacturing Practice (cGMP) regulations. Immediate focus should be placed on identifying and remediating any sanitation or operational deficiencies cited in the Warning Letter to prevent further enforcement action.
FDA Warning Letter issued to: Pamex Foods Incorporated. 05/26/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pamex-foods-incorporated-730351-05262026
Open in openFDA / FDA.gov